Evidence method
Level · gp.fundamentals.debt_to_revenue
35.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Mar 31, 2022
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-22-000017General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
9.14% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.00% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
7.35% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
57.85% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
39.53% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
26.35% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.03% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.76% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 8.93%
- Current
- 35.07%
- Delta
- 26.13%
- Previous
- 8.95%
- Current
- 9.14%
- Delta
- 0.19%
- Previous
- 20.62%
- Current
- 21.00%
- Delta
- 0.38%
- Previous
- 31.89%
- Current
- 7.35%
- Delta
- -24.54%
- Previous
- 13.36%
- Current
- 57.85%
- Delta
- 44.48%
- Previous
- 41.52%
- Current
- 39.53%
- Delta
- -2.00%
- Previous
- 26.57%
- Current
- 26.35%
- Delta
- -0.22%
- Previous
- 1.86%
- Current
- 2.03%
- Delta
- 0.16%
- Previous
- 1.32%
- Current
- 0.76%
- Delta
- -0.56%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · WST CAPEX_INTENSITY_INCREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST GROWTH_DECREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_DECREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.